Successful expression of human factor IX following repeat administration of adenoviral vector in mice.
- 2 April 1996
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (7) , 3056-3061
- https://doi.org/10.1073/pnas.93.7.3056
Abstract
Adenoviral vectors can direct high-level expression of a transgene, but, due to a host immune response to adenoviral antigens, expression is of limited duration, and repetitive administration has generally been unsuccessful. Exposure to foreign proteins beginning in the neonatal period may alter or ablate the immune response. We injected adult and neonatal (immunocompetent) CD-1 mice intravenously with an adenoviral vector expressing human blood coagulation factor IX. In both groups of mice, expression of human factor IX persisted for 12-16 weeks. However, in mice initially injected as adults, repeat administration of the vector resulted in no detectable expression of the transgene, whereas in mice initially injected in the neonatal period, repeat administration resulted in high-level expression of human factor IX. We show that animals that fail to express the transgene on repeat administration have developed high-titer neutralizing antibodies to adenovirus, whereas those that do express factor IX have not. This experimental model suggests that newborn mice can be tolerized to adenoviral vectors and demonstrates that at least one repeat injection of the adenoviral vector is possible; the model will be useful in elucidating the immunologic mechanisms underlying successful repeat administration of adenoviral vectors.Keywords
This publication has 21 references indexed in Scilit:
- Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administrationNature Genetics, 1995
- Mouse embryonic hematopoiesisTrends in Genetics, 1995
- Phenotypic Correction of Hypercholesterolemia in ApoE-Deficient Mice by Adenovirus-Mediated In Vivo Gene TransferArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Tolerance, Danger, and the Extended FamilyAnnual Review of Immunology, 1994
- Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceNature Genetics, 1993
- Widespread long-term gene transfer to mouse skeletal muscles and heart.Journal of Clinical Investigation, 1992
- Human Factor IX in Animals: Kinetics from Isolated, Radiolabelled Protein and Platelet Destruction following Crude Concentrate InfusionsBritish Journal of Haematology, 1980
- A defect in the antigen-presenting function of macrophages from neonatal miceNature, 1979
- FACTOR IX LEVELS IN PATIENTS WITH HEMOPHILIA B (CHRISTMAS DISEASE) FOLLOWING TRANSFUSION WITH CONCENTRATES OF FACTOR IX OR FRESH FROZEN PLASMA (FFP)Medicine, 1977
- ‘Actively Acquired Tolerance’ of Foreign CellsNature, 1953